Rakuten Medical IPO

rakuten-med.com

Rakuten Medical is a biotechnology company focused on developing precision, cell-targeting investigational therapies on its IlluminoxTM platform, which, in pre-clinical studies have shown to lead to rapid and selective cell killing and tumor necrosis.

Founded2013
Total Funding to Date$655.92MM
Register for Details

For more details on financing and valuation for Rakuten Medical, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Rakuten Medical Ticker Symbol

Rakuten Medical does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

Rakuten Medical Stock Price

The stock price for Rakuten Medical will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Rakuten Medical Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
7/28/2021 Series D $166MM raised $XXX.XX $XXX.XX
12/31/2020 Series C-2 $15MM raised $XXX.XX $XXX.XX
7/31/2019 Series C-1 $100.79MM raised $XXX.XX $XXX.XX
12/21/2018 Series C $284.69MM raised $XXX.XX $XXX.XX
9/12/2017 Series B-1 $19MM raised $XXX.XX $XXX.XX
10/5/2016 Series B $56.12MM raised $XXX.XX $XXX.XX
7/30/2015 Series A $14.32MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Other companies like Rakuten Medical in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
 
 
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$4.26B
Sector